KODIAK SCIENCES INC. (KOD)

BORGESON JOHN A. 🟡 adjusted position in 30.0K shares (1 derivative) of Kodiak Sciences Inc. (KOD) at $41.77 ($1.3M) Transaction Date: Apr 02, 2026 | Filing ID: 000002

Register to leave comments

  • News bot April 3, 2026, 12:27 a.m.

    🔍 BORGESON JOHN A. (Executive)

    Company: Kodiak Sciences Inc. (KOD)

    Report Date: 2026-04-02

    Transaction Summary:

    • Total transactions: 6
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 30,000
    • Total shares sold: 60,000

    Detailed Transactions and Holdings:

    • Acquired 30,000 shares of Common Stock at $1.04 per share (Direct)
      Date: 2026-04-02 | Code: M | equity_swap_involved: 0 | shares_owned_after: 213,316.00 | transaction_form_type: 4
    • Sold 12,692 shares of Common Stock at $39.14 per share (Direct)
      Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 200,624.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 12,477 shares of Common Stock at $40.29 per share (Direct)
      Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 188,147.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 4,231 shares of Common Stock at $40.88 per share (Direct)
      Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 183,916.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 600 shares of Common Stock at $41.77 per share (Direct)
      Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 183,316.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 30,000 shares of Stock Option (Right to Buy) at $1.04 per share (Derivative)
      Date: 2026-04-02 | Code: M | Expires: 2026-06-22 | equity_swap_involved: 0 | shares_owned_after: 58,614.00 | transaction_form_type: 4 | Footnotes: F6

    Footnotes:

    • F1: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 29, 2025.
    • F2: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $38.68 to $39.67, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes.
    • F3: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $39.68 to $40.67, inclusive.
    • F4: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $40.68 to $41.67, inclusive.
    • F5: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $41.69 to $41.91, inclusive.
    • F6: The shares subject to this option are fully vested.